Other Events ·
Alterity Therapeutics announced that 18,443,495 listed options (ATHO) will expire on August 31, 2026
PRNAFAlterity Therapeutics Ltd
Alterity Therapeutics announced that 18,443,495 listed options (ATHO) will expire on August 31, 2026. The exercise price is $0.50 per option, with trading ceasing on August 25, 2026. This disclosure fulfills ASX Listing Rule requirements and does not indicate a new financing event or material change in operations. Alterity Therapeutics Limited operates as a clinical-stage biotechnology company developing disease-modifying treatments for neurodegenerative diseases.